A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma

External beam radiation therapy (XRT) with concomitant temozolomide and 6 cycles of adjuvant temozolomide (5/28-day schedule) improves survival in patients with newly diagnosed glioblastoma compared with XRT alone. Studies suggest that dose-dense temozolomide schedules and addition of cytostatic age...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gilbert, Mark R., Gonzalez, Javier, Hunter, Kathy, Hess, Kenneth, Giglio, Pierre, Chang, Eric, Puduvalli, Vinay, Groves, Morris D., Colman, Howard, Conrad, Charles, Levin, Victor, Woo, Shaio, Mahajan, Anita, de Groot, John, Yung, W.K. Alfred
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2010
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098026/
https://ncbi.nlm.nih.gov/pubmed/20729242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados